E-Z-EM completes Eagle Acquisition Sub merger

E-Z-EM has completed the merger of Eagle Acquisition Sub, a wholly owned subsidiary of Bracco Diagnostics, with E-Z-EM, and the other transactions contemplated by the agreement and plan of merger, among Bracco, Eagle Acquisition, E-Z-EM and, for the limited purposes specified therein, Bracco Imaging.

Under the terms of the merger agreement, each outstanding common share of E-Z-EM was converted into the right to receive $21 in cash, without interest and less any required withholding tax. E-Z-EM is now a wholly owned subsidiary of Bracco.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.